TREATING OR REDUCING THE RISK OF CARDIOVASCULAR DISEASE

Methods of treating and/or preventing a cardiovascular disease in a human suffering from an allergic and/or inflammatory condition of the skin or upper airway passages or cardiovascular disease by administrating an effective amount of an antihistamine, preferably desloratadine, alone, or in admixtur...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HARRIS, ALAN, G, MEDEIROS, PAUL, T
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator HARRIS, ALAN, G
MEDEIROS, PAUL, T
description Methods of treating and/or preventing a cardiovascular disease in a human suffering from an allergic and/or inflammatory condition of the skin or upper airway passages or cardiovascular disease by administrating an effective amount of an antihistamine, preferably desloratadine, alone, or in admixture with an effective amount of at least one leukotriene antagonist, preferably, montelukast, for such reducing and/or preventing are disclosed. La présente invention concerne un traitement prophylactique ou thérapeutique d'une affection cardio-vasculaire chez un humain souffrant d'un état allergique et/ou inflammatoire de la peau ou des voies respiratoires supérieures ou d'une affection cardio-vasculaire. Ce traitement consiste en une administration d'une quantité efficace d'au moins un antagoniste du leukotriène, de préférence le montelukast, en vue d'une telle prophylaxie ou thérapie.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO02067938A3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO02067938A3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO02067938A33</originalsourceid><addsrcrecordid>eNrjZDAPCXJ1DPH0c1fwD1IIcnUJdQaxQzxcFYI8g70V_N0UnB2DXDz9wxyDnUN9HIMUXDyDXR2DXXkYWNMSc4pTeaE0N4Oim2uIs4duakF-fGpxQWJyal5qSXy4v4GRgZm5pbGFo7ExMWoAMqsoRA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>TREATING OR REDUCING THE RISK OF CARDIOVASCULAR DISEASE</title><source>esp@cenet</source><creator>HARRIS, ALAN, G ; MEDEIROS, PAUL, T</creator><creatorcontrib>HARRIS, ALAN, G ; MEDEIROS, PAUL, T</creatorcontrib><description>Methods of treating and/or preventing a cardiovascular disease in a human suffering from an allergic and/or inflammatory condition of the skin or upper airway passages or cardiovascular disease by administrating an effective amount of an antihistamine, preferably desloratadine, alone, or in admixture with an effective amount of at least one leukotriene antagonist, preferably, montelukast, for such reducing and/or preventing are disclosed. La présente invention concerne un traitement prophylactique ou thérapeutique d'une affection cardio-vasculaire chez un humain souffrant d'un état allergique et/ou inflammatoire de la peau ou des voies respiratoires supérieures ou d'une affection cardio-vasculaire. Ce traitement consiste en une administration d'une quantité efficace d'au moins un antagoniste du leukotriène, de préférence le montelukast, en vue d'une telle prophylaxie ou thérapie.</description><edition>7</edition><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2003</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20030717&amp;DB=EPODOC&amp;CC=WO&amp;NR=02067938A3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20030717&amp;DB=EPODOC&amp;CC=WO&amp;NR=02067938A3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HARRIS, ALAN, G</creatorcontrib><creatorcontrib>MEDEIROS, PAUL, T</creatorcontrib><title>TREATING OR REDUCING THE RISK OF CARDIOVASCULAR DISEASE</title><description>Methods of treating and/or preventing a cardiovascular disease in a human suffering from an allergic and/or inflammatory condition of the skin or upper airway passages or cardiovascular disease by administrating an effective amount of an antihistamine, preferably desloratadine, alone, or in admixture with an effective amount of at least one leukotriene antagonist, preferably, montelukast, for such reducing and/or preventing are disclosed. La présente invention concerne un traitement prophylactique ou thérapeutique d'une affection cardio-vasculaire chez un humain souffrant d'un état allergique et/ou inflammatoire de la peau ou des voies respiratoires supérieures ou d'une affection cardio-vasculaire. Ce traitement consiste en une administration d'une quantité efficace d'au moins un antagoniste du leukotriène, de préférence le montelukast, en vue d'une telle prophylaxie ou thérapie.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2003</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAPCXJ1DPH0c1fwD1IIcnUJdQaxQzxcFYI8g70V_N0UnB2DXDz9wxyDnUN9HIMUXDyDXR2DXXkYWNMSc4pTeaE0N4Oim2uIs4duakF-fGpxQWJyal5qSXy4v4GRgZm5pbGFo7ExMWoAMqsoRA</recordid><startdate>20030717</startdate><enddate>20030717</enddate><creator>HARRIS, ALAN, G</creator><creator>MEDEIROS, PAUL, T</creator><scope>EVB</scope></search><sort><creationdate>20030717</creationdate><title>TREATING OR REDUCING THE RISK OF CARDIOVASCULAR DISEASE</title><author>HARRIS, ALAN, G ; MEDEIROS, PAUL, T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO02067938A33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2003</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>HARRIS, ALAN, G</creatorcontrib><creatorcontrib>MEDEIROS, PAUL, T</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HARRIS, ALAN, G</au><au>MEDEIROS, PAUL, T</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>TREATING OR REDUCING THE RISK OF CARDIOVASCULAR DISEASE</title><date>2003-07-17</date><risdate>2003</risdate><abstract>Methods of treating and/or preventing a cardiovascular disease in a human suffering from an allergic and/or inflammatory condition of the skin or upper airway passages or cardiovascular disease by administrating an effective amount of an antihistamine, preferably desloratadine, alone, or in admixture with an effective amount of at least one leukotriene antagonist, preferably, montelukast, for such reducing and/or preventing are disclosed. La présente invention concerne un traitement prophylactique ou thérapeutique d'une affection cardio-vasculaire chez un humain souffrant d'un état allergique et/ou inflammatoire de la peau ou des voies respiratoires supérieures ou d'une affection cardio-vasculaire. Ce traitement consiste en une administration d'une quantité efficace d'au moins un antagoniste du leukotriène, de préférence le montelukast, en vue d'une telle prophylaxie ou thérapie.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO02067938A3
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title TREATING OR REDUCING THE RISK OF CARDIOVASCULAR DISEASE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T22%3A25%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HARRIS,%20ALAN,%20G&rft.date=2003-07-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO02067938A3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true